首页|HbA、HbA2及HbF与地中海贫血基因检测联合诊断地中海贫血的临床意义

HbA、HbA2及HbF与地中海贫血基因检测联合诊断地中海贫血的临床意义

扫码查看
目的 本研究将血红蛋白A(HbA)、血红蛋白A2(HbA2)及血红蛋白F(HbF)与地中海贫血基因检测联合诊断应用于地中海贫血的诊断中,并对该方式的诊断效能进行分析.方法 70 例疑似地中海贫血患者,随机分为研究组和对照组,每组 35 例.同期纳入在本院接受健康体检的 50 例正常人作为健康组.对照组和健康组进行血红蛋白电泳检测(HbA、HbA2、HbF),研究组实施血红蛋白电泳检测和地中海贫血基因检测.对比研究组和对照组患者的地中海贫血检出率,并对比α-地中海贫血患者、β-地中海贫血患者以及健康组的HbA、HbA2 及HbF水平,分析HbA、HbA2、HbF联合地中海贫血基因检测诊断地中海贫血的受试者工作特征曲线(ROC曲线).结果 研究组的α-地中海贫血检出率为 34.29%、β-地中海贫血检出率为 54.29%,对照组的α-地中海贫血检出率为 31.43%、β-地中海贫血检出率为 37.14%,研究组地中海贫血总检出率(88.57%)高于对照组(68.57%),差异有统计学意义(P<0.05).α-地中海贫血患者、β-地中海贫血患者、健康组的HbA水平对比,差异无统计学意义(P>0.05);α-地中海贫血患者、β-地中海贫血患者、健康组的HbF、HbA2 水平对比,差异有统计学意义(P<0.05).其中β-地中海贫血患者的HbF水平(5.87±1.56)%、HbA2 水平(5.62±1.67)%高于α-地中海贫血患者的(1.67±0.52)%、(1.51±0.34)%以及健康组的(1.21±0.19)%、(2.81±0.92)%;α-地中海贫血患者的HbA2 水平低于健康组,而HbF水平高于健康组,差异有统计学意义(P<0.05).以HbA、HbA2、HbF与地中海贫血基因检测为检验变量,设置 1 为患病、0 为未患病作为效应变量绘制ROC曲线:其中HbA、HbA2、HbF诊断的曲线下面积(AUC)值为 0.703,95%置信区间(CI)=(0.554,0.852),灵敏度为 67.3%,特异度为 73.3%;HbA、HbA2、HbF联合地中海贫血基因检测诊断的AUC值为 0.852,95%CI=(0.736,0.967),灵敏度为 83.6%,特异度为 86.7%.结论 在对地中海贫血进行诊断时采取HbA、HbA2、HbF联合地中海贫血基因检测,具有较高的诊断效能,并且能够有效鉴别地中海贫血的疾病类型,在后续开展的相关治疗中具有重要意义.
Clinical significance of HbA,HbA2 and HbF combined with thalassemia gene test in diagnosis of thalassemia
Objective In this study,hemoglobin A(HbA),hemoglobin A2(HbA2)and hemoglobin F(HbF)combined with thalassemia gene test was applied in the diagnosis of thalassemia,and the diagnostic efficacy of this method was analyzed.Methods 70 patients with suspected thalassemia were randomly divided into a control group and a study group,each consisting of 35 cases.Another 50 normal subjects who received physical examination in our hospital during the same period were included as the healthy group.The control group and the healthy group were tested by hemoglobin electrophoresis(HbA,HbA2 and HbF),and the study group was tested by hemoglobin electrophoresis combined with thalassemia gene.The thalassemia detection rates of patients in the study group and control group were compared,and then the HbA,HbA2 and HbF levels in the α-thalassemia patients,β-thalassemia patients and the healthy group were compared,and the receiver operating characteristic(ROC)curve of HbA,HbA2 and HbF combined with the thalassemia gene test for thalassemia was analyzed.Results In the study group,the detection rate of α-thalassemia was 34.29%,and the detection rate of β-thalassemia was 54.29%;in the control group,the detection rate of α-thalassemia was 31.43%,and the detection rate of β-thalassemia was 37.14%.The total detection rate of thalassemia in the study group(88.57%)was higher than that in the control group(68.57%),and the difference was statistically significant(P<0.05).Comparison of HbA levels in α-thalassemia patients,β-thalassemia patients,and healthy group,the difference was not statistically significant(P>0.05).Comparison of HbF and HbA2 levels in α-thalassemia patients,β-thalassemia patients,and healthy group,the difference was statistically significant(P<0.05).HbF level of(5.87±1.56)%and HbA2 level of(5.62±1.67)%in β-thalassemia patients were higher than those in α-thalassemia patients[(1.67±0.52)%and(1.51±0.34)%]and healthy group[(1.21±0.19)%and(2.81±0.92)%];HbA2 level in the patients with α-thalassemia was lower than that in the healthy group,while the HbF level was higher than that in the healthy group,and the difference was statistically significant(P<0.05).The ROC curve was plotted with HbA,HbA2,HbF and thalassemia genetic test as test variables,setting 1 as diseased and 0 as not diseased as effect variables:the AUC value of the diagnosis of HbA,HbA2,HbF was 0.703,with 95%confidence interval(CI)of(0.554,0.852),a sensitivity of 67.3%and a specificity of 73.3%;the area under the curve(AUC)value of combined diagnosis of HbA,HbA2,HbF and thalassemia genetic test was 0.852,with 95%CI=(0.736,0.967),a sensitivity of 83.6%,and a specificity of 86.7%.Conclusion In the diagnosis of thalassemia,HbA,HbA2 and HbF combined with thalassemia gene test has high diagnostic efficacy,and can effectively identify the disease types of thalassemia,which is of great significance for the subsequent related treatment.

Hemoglobin AHemoglobin A2Hemoglobin FThalassemia gene testThalassemia

何月敬、胡勉裕、叶敏南、程敏、李清香、周家怡、张川州、黎四平

展开 >

523325 东莞市第八人民医院临床检验科

血红蛋白A 血红蛋白A2 血红蛋白F 地中海贫血基因检测 地中海贫血

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(20)